MY103505A - Hetercoyclic oxophthalazinyl acetic acids - Google Patents
Hetercoyclic oxophthalazinyl acetic acidsInfo
- Publication number
- MY103505A MY103505A MYPI88001483A MYPI19881483A MY103505A MY 103505 A MY103505 A MY 103505A MY PI88001483 A MYPI88001483 A MY PI88001483A MY PI19881483 A MYPI19881483 A MY PI19881483A MY 103505 A MY103505 A MY 103505A
- Authority
- MY
- Malaysia
- Prior art keywords
- hetercoyclic
- alkylamino
- hydroxy
- hydrogen
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13617987A | 1987-12-21 | 1987-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY103505A true MY103505A (en) | 1993-06-30 |
Family
ID=22471693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI88001483A MY103505A (en) | 1987-12-21 | 1988-12-20 | Hetercoyclic oxophthalazinyl acetic acids |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0322153A3 (xx) |
| JP (1) | JPH0692402B2 (xx) |
| KR (1) | KR910000438B1 (xx) |
| CN (1) | CN1035116A (xx) |
| AU (1) | AU609559B2 (xx) |
| CA (1) | CA1299181C (xx) |
| DK (1) | DK712388A (xx) |
| FI (1) | FI885886A (xx) |
| HU (1) | HU207086B (xx) |
| IL (1) | IL88729A (xx) |
| MX (1) | MX14287A (xx) |
| MY (1) | MY103505A (xx) |
| NZ (1) | NZ227441A (xx) |
| PT (1) | PT89268B (xx) |
| YU (1) | YU46578B (xx) |
| ZA (1) | ZA889519B (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954629A (en) * | 1989-05-11 | 1990-09-04 | Pfizer Inc. | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
| US5064830A (en) * | 1990-08-02 | 1991-11-12 | Pfizer Inc. | Lowering of blood uric acid levels |
| FR2682108B1 (fr) * | 1991-10-07 | 1994-01-07 | Lipha | Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant. |
| US5391551A (en) * | 1993-05-10 | 1995-02-21 | Pfizer Inc. | Method of lowering blood lipid levels |
| US5700819A (en) * | 1994-11-29 | 1997-12-23 | Grelan Pharmaceutical Co., Ltd. | 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications |
| IL124236A (en) * | 1997-05-05 | 2003-01-12 | Pfizer | Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor |
| US6878522B2 (en) | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| CN101058558B (zh) * | 2007-05-28 | 2013-04-10 | 沈阳药科大学 | 具有醛糖还原酶抑制活性的4-氧代-1(4h)-喹啉羧酸类化合物、组合物及其制备方法 |
| FR2926556B1 (fr) * | 2008-01-22 | 2010-02-19 | Sanofi Aventis | Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4748280A (en) | 1985-11-07 | 1988-05-31 | Pfizer Inc. | Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6) |
| CA1299178C (en) * | 1985-11-07 | 1992-04-21 | Banavara Lakshmana Mylari | Heterocyclic oxophtalazinyl acetic acids |
| IL80475A (en) * | 1985-11-07 | 1993-01-31 | Pfizer | Heterocyclic-substituted 4-oxo (or thio)-3h- phthalazinyl-acetic acid derivatives and pharmaceutical compositions containing them |
| ES2031813T3 (es) * | 1985-11-11 | 1993-01-01 | Asta Pharma Ag | Procedimiento para la preparacion de derivados de 4-bencil-1-(2h)-ftalazinona. |
| JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
| JPS6419077A (en) * | 1987-07-13 | 1989-01-23 | Yamanouchi Pharma Co Ltd | Thiazolidine derivative |
-
1988
- 1988-12-15 EP EP88311857A patent/EP0322153A3/en not_active Withdrawn
- 1988-12-16 CA CA000586121A patent/CA1299181C/en not_active Expired - Fee Related
- 1988-12-19 IL IL8872988A patent/IL88729A/en not_active IP Right Cessation
- 1988-12-20 FI FI885886A patent/FI885886A/fi not_active Application Discontinuation
- 1988-12-20 KR KR1019880017067A patent/KR910000438B1/ko not_active IP Right Cessation
- 1988-12-20 MY MYPI88001483A patent/MY103505A/en unknown
- 1988-12-20 PT PT89268A patent/PT89268B/pt not_active IP Right Cessation
- 1988-12-20 YU YU230788A patent/YU46578B/sh unknown
- 1988-12-20 HU HU886506A patent/HU207086B/hu not_active IP Right Cessation
- 1988-12-21 CN CN88109263A patent/CN1035116A/zh active Pending
- 1988-12-21 AU AU27337/88A patent/AU609559B2/en not_active Ceased
- 1988-12-21 DK DK712388A patent/DK712388A/da not_active Application Discontinuation
- 1988-12-21 JP JP63323225A patent/JPH0692402B2/ja not_active Expired - Fee Related
- 1988-12-21 ZA ZA889519A patent/ZA889519B/xx unknown
- 1988-12-21 MX MX1428788A patent/MX14287A/es unknown
- 1988-12-21 NZ NZ227441A patent/NZ227441A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU207086B (en) | 1993-03-01 |
| PT89268B (pt) | 1993-07-30 |
| JPH01211585A (ja) | 1989-08-24 |
| FI885886A (fi) | 1989-06-22 |
| HUT56552A (en) | 1991-09-30 |
| CN1035116A (zh) | 1989-08-30 |
| CA1299181C (en) | 1992-04-21 |
| IL88729A (en) | 1996-07-23 |
| MX14287A (es) | 1993-06-01 |
| PT89268A (pt) | 1989-12-29 |
| EP0322153A3 (en) | 1990-08-16 |
| JPH0692402B2 (ja) | 1994-11-16 |
| FI885886A0 (fi) | 1988-12-20 |
| KR890009888A (ko) | 1989-08-04 |
| IL88729A0 (en) | 1989-07-31 |
| NZ227441A (en) | 1990-12-21 |
| DK712388A (da) | 1989-07-31 |
| AU2733788A (en) | 1989-06-22 |
| DK712388D0 (da) | 1988-12-21 |
| EP0322153A2 (en) | 1989-06-28 |
| YU46578B (sh) | 1993-11-16 |
| ZA889519B (en) | 1990-08-29 |
| AU609559B2 (en) | 1991-05-02 |
| YU230788A (en) | 1990-10-31 |
| KR910000438B1 (ko) | 1991-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3020848T3 (en) | 1,8-Naphthyridin-2-one derivatives | |
| DE68916071D1 (de) | 3-Pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en-2-carbonsäure-Verbindungen. | |
| ATE132150T1 (de) | 3-alkenyl-1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure-verbindungen | |
| ATE109149T1 (de) | 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen. | |
| EP0237986A3 (en) | Flavone carboxylic acid derivatives | |
| ATE252074T1 (de) | Phenylalkylcarbonsäure-derivate | |
| MY103505A (en) | Hetercoyclic oxophthalazinyl acetic acids | |
| FI911016A0 (fi) | Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi | |
| AU6731100A (en) | Integrase inhibitors containing aromatic heterocycle derivatives | |
| MY101815A (en) | Heterocyclic oxophthalazinyl acetic acids. | |
| CA2053705A1 (en) | Piperazine derivatives | |
| ES8704495A1 (es) | Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo. | |
| AU624724B2 (en) | Pyrrolo(2,1-b)thiazole derivatives | |
| DE3572815D1 (de) | 1,3-dithiole derivatives | |
| GEP19960472B (en) | Method of producing derivative of quinoline or its pharmaceutically acceptable ester, or their salts |